INS and invasive breast carcinoma: Analysis of a TMA containing 90 samples from patients with invasive breast cancer showed that 78 of 90 (~ 87%) of these patients have Insulin/IGF1 receptors activated (Fig. 2b, upper pie diagram, and Supplementary Table S2).